Amaury Wittouck Net Worth & Insider Trades

Amaury Wittouck - Director, Lexicon Pharmaceuticals, Inc

As of August 9, 2022

What is Amaury Wittouck's Net Worth?

The current estimated net worth of Lexicon Pharmaceuticals, Inc's Director, Amaury Wittouck, is estimated to be about $260.59M . Amaury Wittouck owns about 86,262,020 units of Lexicon Pharmaceuticals, Inc common stock. Recently at Lexicon Pharmaceuticals, Inc, Amaury Wittouck has sold an estimated value of $0 worth.

What is Amaury Wittouck's Past Insider Trading?

Amaury Wittouck's largest purchase order was 16,173,800 units , worth over $40.43M on August 1, 2022. In total, Amaury Wittouck has made about 2 transactions recently at Lexicon Pharmaceuticals, Inc. Amaury Wittouck usually trades in August, with the busiest year in 2022. The most recent transaction was a purchase order of 2,426,070 units , worth over $6.07M on August 9, 2022.

Artal International SCA, Amaury Wittouck, Artal International Management SA, SA Group Artal, SA Westend, Westend Administratiekantoor Stichting, Invus Public Equities LP, Invus LP, Invus Public Equities Advisors LLC, Invus Advisors LLC

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Amaury Wittouck's' Mailing Address?

  • Mailing address is Valley Park 44, Rue de la Vallee Luxembourg N4 L2661 Luxembourg

What are Lexicon Pharmaceuticals, Inc's Past Insider Trades?

Lexicon Pharmaceuticals, Inc's most recent insider trade came on August 9, 2022 by Invus Us Partners Llc, Ulys Llc and Raymond Debbane who bought 147,390 units worth $368.48K . In the last 15 years, insiders at Lexicon Pharmaceuticals, Inc have sold an estimated value of $4.48M and bought an estimated value of $787.45M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Jeffrey L Wade, President and CFO,  Alan J Main, EVP,  and Raymond Debbane, Director .

LEXICON PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...